The Role of Cyclodextrins in COVID-19 Therapy-A Literature Review
Coronavirus disease-19 (COVID-19) emerged in December 2019 and quickly spread, giving rise to a pandemic crisis. Therefore, it triggered tireless
Tag: antiviral
Patent application on reduction of envelope viral particle number in a composition containing cyclodextrin
US patent application US2022409653 entitled “METHOD FOR PREVENTING ENTRY AND REPLICATION OF ENVELOPED VIRUSES” descibes a method for the reduction
HPβ-CD as affordable antiviral to treat coronavirus infection
In a recent study posted to the bioRxiv* preprint server, researchers identified β-cyclodextrins (β-CDs) as a safe and cost-effective drug
Gilead Statement on Veklury® (Remdesivir) and the SARS-CoV-2 Omicron Variant
Gilead has conducted an analysis of genetic information currently available for the Omicron variant and found no additional prevalent mutations
First results on cyclodextrins against dengue fever from CycloLab
In May, 2020, CycloLab announced a collaboration, where University of California, Berkeley, Excivion and CycloLab teamed-up to evaluate the antiviral
UofA lab uncovers new mechanism of action against SARS-CoV-2 by antiviral drug remdesivir
News Release on 23-Sep-2020 on Eurokalert Researchers at the University of Alberta have discovered a novel, second mechanism of action
Pfizer agrees to manufacture Gilead’s coronavirus drug remdesivir
Pfizer has agreed to manufacture and supply Gilead Sciences’ antiviral drug remdesivir, the pharmaceutical giant announced Friday. The multiyear agreement will support efforts to
Wacker on cyclodextrins in the COVID fight
The world’s largest cyclodextrin producer, Wacker Chemie has recently published a press release on cyclodextrins and their role in the
ALL EYES ON GILEAD
Bloombergs Businessweek published the story on how Gilead scineces prepared for the recently obtained emergency approval of the antiviral drug
Voluntary Licensing Agreements for Remdesivir
Gilead has signed non-exclusive voluntary licensing agreements with five generic pharmaceutical manufacturers based in India and Pakistan to further expand